TARA

Protara Therapeutics
$4.04
+$0.02 (+0.5%)Jul 27, 2026
0.8PoorMoatMint rating

MoatMint rates Protara Therapeutics (TARA) 0.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.8 out of 10.

Key metrics

The numbers that frame TARA today
Market cap
$227.07M
P/E (TTM)
-3.6
EV / FCF
-3.4
ROIC
-44.5%
Div yield
0%
Debt / equity
0.0
52wk Low
$2.97
52wk High
$7.82

TARA stock rating

How TARA scores on quality, value, growth, momentum and financial health
0.8out of 10
Low overallNeutral business, expensive priceTop 92% of ~5,000 US stocks
QualityPoor0.8/10
GrowthFair3.9/10
MomentumFair3.0/10
ValuePoor1.3/10
Financial HealthFair2.4/10

Growth

Revenue and earnings trend for TARA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about TARA
Is Protara Therapeutics a good buy?
No. Protara Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Protara Therapeutics is selling at a very high price.
What is the market capitalization of TARA?
Protara Therapeutics's market capitalization is $227.07M.
What is the P/E ratio for TARA stock?
Protara Therapeutics's current P/E ratio is -3.6.
What is the 52-week high for TARA stock?
The 52-week high for Protara Therapeutics is $7.82. The current close of $4.04 is 48.3% below that high.
What is the 52-week low for TARA stock?
The 52-week low for Protara Therapeutics is $2.97. The current close of $4.04 is 36% above that low.
Does TARA stock pay dividends?
Protara Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TARA?
Protara Therapeutics's Debt / Equity ratio is 0.02.